see the curriculum vitae
TRANSCRIPT
Curriculum Vitae(Updated 5/04)
Benjamin D. Li, M.D., F.A.C.S.Professor of Surgery
Chief, Division of Surgical OncologyLouisiana State University Health Sciences Center
Co-Director, Breast and Solid Tumor ProgramFeist-Weiller Cancer Center
PERSONAL:
Office Address: Department of SurgeryLouisiana State Univ. Health Sciences Center
1501 Kings HighwayShreveport, LA 71130
E-mail Address: [email protected]
Telephone: 318 675 6123FAX: 318 675 4689
Home Address: 1126 Kelliwood DriveShreveport, LA 71106
Telephone: 318 798 1459
Birth Date: June 3, 1960
Marital Status: Married; 2 childrenSpouse: Mary
Citizenship: United States
EDUCATION:
1
1982 B.A. (with Highest Honors) University of Hawaii, Microbiology Honolulu, HI
1986 M.D. Yale Medical School, New Haven, CT
POSTGRADUATE TRAINING:
Internship and Residency:
1986 - 1987 Internship in General Surgery, Northwestern University, Chicago, IL
1987 - 1990 Residency in General Surgery, Northwestern University, Chicago, IL
1991 - 1992 Chief Resident, General Surgery, Northwestern University, Chicago, IL
Research Fellowships:
1990 - 1991 Research FellowLurie Cancer Center and Dept. of Surgery, Northwestern University, Chicago, ILMentor: Rosemary B. Duda, M.D.
1992 - 1994 T-32 NIH Laboratory Research Fellowship, Depts. of Surgical Oncology and Flow Cytometry, Roswell Park Cancer Institute, Buffalo, NYMentor: Carleton C. Stewart, Ph.D.
Clinical Fellowship:
1994 - 1995 Administrative Chief and Clinical Fellow, Surgical Oncology,Roswell Park Cancer Institute, Buffalo, NY
2
LICENSURE:
1988 State of Illinois (Inactive) No. 036-0799451992 State of New York (Inactive) No. 1894411995 State of Louisiana No. 11536R
BOARD CERTIFICATION:
1987 National Board of Medical Examiners No. 3190471993 American Board of Surgery No. 384722002 Recertified, American Board of Surgery
ACADEMIC APPOINTMENTS:
1991 - 1992 Assistant Clinical Instructor in Surgery, Northwestern University Medical School
1992 - 1995 Clinical Assistant Instructor in Surgery, State University of New York, Buffalo, NY
1994 - 1995 Administrative Chief Fellow, Roswell Park Cancer Institute, Buffalo, NY
1996 - 2000 Assistant Professor of Surgery, Louisiana State University, Shreveport, LA
2000 - 2003 Associate Professor of Surgery (with Tenure), Louisiana State University, Shreveport, LA
2003 Professor of Surgery (with Tenure),Louisiana State University,Shreveport, LA
HOSPITAL APPOINTMENTS:
3
1996 - present Chief, Division of Surgical Oncology, Louisiana State Univ. Health Sciences Center, Shreveport, LA
1996 - 2003 Co-Director, Breast Cancer ProgramFeist-Weiller Cancer CenterLouisiana State University Health Sciences Center,Shreveport, LA
1996 - present Consultant Surgeon, E. A. Conway Hospital, Monroe, LA
1996 - present Consultant Surgeon, Overton-Brooks V.A. Medical Center, Shreveport, LA
1996 - present Consultant Surgeon, Willis-Knighton Medical Center, Shreveport, LA
1996 - present Consultant Surgeon,Doctor’s HospitalShreveport, LA
2003 - present Co-Director,Breast and Solid Tumor ProgramFeist-Weiller Cancer CenterLouisiana State University Health Sciences Center,Shreveport, LA
4
MAJOR COMMITTEE ASSIGNMENTS:
National Organizations:
2000 - 2002 Councilor, Association for Academic Surgery
2000 - 2004 Executive Council, Association for Academic Surgery
2000 - present Principal Investigator, American College of Surgeon Oncology Group
2001 Strategic Planning Committee, Association for Academic Surgery
2001 Sarcoma Committee, Southwest Oncology Group (S.W.O.G.)
2001 Cytogenetics Working GroupS.W.O.G.
2001 - 2002 Nominating Committee,Association for Academic Surgery
2002 Breast Committee,S.W.O.G.
2002 Surgery Committee,S.W.OG.
2002 G.I. Committee,S.W.O.G.
2002 - present Louisiana State ChairAmerican College of Surgeons,Commission on Cancer/Cancer Physician Liaison Program
2002 Strategic Planning Retreat,Association for Academic Surgery
2002 - 2004 Ad Hoc Committee,
5
Association for Academic Surgery – Society of University Surgeons Joint Task Force
2002 – 2004 Representative to the National Associationfor Biomedical Research(Association for Academic Surgery appointment)
2003 Committee on Cancer Liaison American College of Surgeons Commission on Cancer/Cancer Physician Liaison Program
2003 Oversight Committee for the T32 Training Program, Roswell Park Cancer Institute
2004 -2007 Membership CommitteeSociety of University Surgeons
2004 Comprehensive Cancer Control Leadership InstitutesPhase II
State/Regional Organizations:
1997 - 1998 Young Surgeon Representative, LA Chapter, American College of Surgeons
1997 - 1998 Executive Council, Surgical Association of Louisiana and LA Chapter, American College Surgeons
1999 - 2000 Executive Council, Surgical Association of Louisiana and LA Chapter, American College Surgeons
2000 Program Chairman, Joint Meeting of the LA Chapter, American College of Surgeons and Surgical Association of Louisiana
2001 Committee member,Congress for Cancer Control
2002 - 2005 Chairman, Cancer Committee LA Chapter, American College of Surgeons
6
2002 - 2005 Executive Council, LA Chapter, American College of Surgeons
2002 - present Committee member,Cancer Early Detection and Prevention GroupLouisiana Cancer Control Partnership
2003 - present Co-Chair, Executive Committee.Louisiana Cancer Control Partnership
2003 - present Health Initiative Action TeamAmerican Cancer Society
Medical School Committees:
1997 - 2000 Research Advisory Committee
1998 - 1999 Medical School Curriculum Committee
1998 - 1999 Dean’s Committee on Long Range Research Planning
1998 - present Ad Hoc Committee on Tissue Procurement
1998 - 1999 Clinical Research Committee
1999 - 2000 Dean’s Task Force on Medical School Curriculum
2000 - present Ad Hoc Search Committee for Chairman of Surgery
2000 - present Research Council
2001 Ad Hoc Research Investigation Board
2001 - 2002 Ad Hoc Long Range Planning CommitteeChairman, Clinical Research Subcommittee
2001 Ad Hoc Search Committee for the Feist-Weiller Chair of Cancer
2002 – present Coordinator and moderator,Dept. of Surgery Research Conference
7
2002 Chairman, Ad Hoc Committee on Surgery Clinical Rotation
2002 Ad Hoc Search Committee for Director of Breast Imaging
2002 - present Internal Review Board Feist-Weiller Cancer Center
2003 Chairman, Ad Hoc Search Committee for Chair of Cardiothoracic Surgery
2003 Board of DirectorsFeist-Weiller Cancer Center
Hospital Committees:
1996 - 1999 Cancer Liaison Physician, American College of Surgeons
1996 - 2001 Chairman, Cancer Committee
1996 - 2001 Hospital Clinical Board
1996 - present Coordinator, Multidisciplinary Tumor Board
2001 - present Cancer Liaison Physician, American College of Surgeons
PROFESSIONAL SOCIETIES:
National Organizations:
1992 American Association for Cancer Research*
1995 Association for Academic Surgery*
1995 Southwest Oncology Group
1995 Roswell Park Surgical Society
1996 American Medical Association
1996 American Society for Gastrointestinal Endoscopy*
1996 American Society of Clinical Oncology*
1997 Society of Surgical Oncology *
8
1998 Southeastern Surgical Congress*
1998 American Society of Colon and Rectal Surgeons*
1999 American College of Surgeons*
2000 American Society of Breast Surgeons
2000 American College of Surgeons Oncology Group
2000 Southern Surgical Association*
2000 Society of University Surgeons*
(*elected membership)
State Organizations:
1996 Louisiana Chapter, American College of Surgeons
1996 Louisiana State Medical Society
1996 Shreveport Medical Society*
1996 Shreveport Surgical Society*
1997 Surgical Association of Louisiana*
(*elected membership)
HONOR SOCIETIES:
1980 Mortar Board
1981 Phi Kappa Phi
1982 Phi Beta Kappa
2001 Alpha Omega Alpha (faculty)
AWARDS/HONORS:
1980 Minority Access to Research Career Award
1981 American Society for Microbiology Research Award
1982 Arthur Lyman Dean's Prize for Research
1982 Chancellor's Award for Academic Excellence
9
1982 Pacific Health Research Institute Award
1982 NIH Medical Student Summer Fellowship
1991 Northwestern University Medical School Outstanding Resident Teacher Award (Elected by the Class of 1991)
1992 Outstanding Surgical Resident Teacher of the YearDepartment of Surgery, Northwestern University Medical School
1993 Northwestern University Medical School Outstanding Resident Teacher Award (Elected by the Class of 1993)
1994 Best Scientific Paper, Roswell Park Cancer Institute
1995 Best Scientific Paper, Roswell Park Cancer Institute
1996 Marquis Who’s Who In Science and Engineering
1997 Young Surgeon Representative, Louisiana Chapter, American College of Surgeons
1998 Marquis Who’s Who In Medicine
2000 Marshall for the LSU Medical School Graduation(Elected by the Class of 2000)
2001 Alpha Omega Alpha Faculty Award
2001 The Shipley Medal’s for Research,Southern Surgical Association
2002 America’s Top Surgeons, Consumers’ Research Council
2002 Marquis Who’s Who in America
10
RESEARCH FUNDINGS:
1. Agency: Dept. of Defense - U.S. Army Amount: $307,638Medical Research and Materiel CommandCongressionally Directed Medical Research Programs: BC984008Title: “High eIF4E Overexpression in Node Negative Breast Cancer as Predictor for Recurrence”Role: Principal Investigator Effort: 20%Period of Support: 7/99-6/2003
2. Agency: National Institutes of Health Amount: $107,417NCI Grant No. CA80704Title: “Diet and Lifestyle-related Insulin-like Growth Factor-I Expression and Breast Cancer Risk”PI: Herbert Yu, M.D, Ph.D.Role: Co-Investigator Effort: 5%Period of Grant: 1/99-1/2002
3. Agency: National Institutes of Health Amount: $281,509NCI Grant No. CA77496Title: “Prognostic and Therapeutic Role of c-kit in Breast Cancer”PI: B. Jill Williams, Ph.D.Role: Co-Investigator Period of Grant: 1/99-1/2002 Effort: 5%
4. Agency: National Institutes of Health Amount: $100,000NCI Grant No. CA79082Title: “eIF4E Overexpression and Breast Cancer Recurrence”Role: Principal Investigator Effort: 15%
Period of Grant: 10/98-9/2000
5. Agency: Oral and Maxillofacial Surgery Foundation Amount: $110,000Title: "Mechanism of eIF-4E Overexpression and its Clinical Implications in Head and Neck Cancer"Role: Principal Investigator Effort: 30%Period of Grant: 3/97-3/99
6. Agency: Veterans of Foreign Wars Auxiliary Group Amount: $16,832 Title: “Breast Cancer Research”Role: Principal Investigator
11
7. Agency: Society of Surgical Oncology Amount: $2,000Title: "Correlation of Eukaryotic Initiation Factor 4E (eIF4E) Gene Amplification and Expression by Fluorescence In Situ Hybridization (FISH) and the Clinical Outcome in Breast Cancer"Role: Faculty Mentor Student: Destin BlackPeriod of Grant: 1997
8. Agency: American Cancer Society Amount: $2,500Title: "Quantitative Analysis of eIF4E Gene Amplification by Competitive PCR and the Clinical Outcome of Breast Cancer"Role: Faculty MentorStudent: Donald BeamPeriod of Grant: 1997
9. Agency: Deltec/Smiths Industries Medical Systems Amount: $3,000Title: “Long-term patency and clinical outcomes in implantable peripheral access port-a-cath using low dose coumadin versus placebo” Role: Principal Investigator Effort: 5%Period of Grant: 1997
10. Agency: American Cancer Society Amount: $2,500Title: "HER-2/neu Amplification in Head and Neck Cancer"Role: Faculty Mentor Student: Robert DeFattaPeriod of Grant: 1996
11. Agency: American Cancer Society Amount: $2,500Title: "Correlating Overexpression of Initiation Factor eIF4E to Gene Amplification in Breast Cancer"Role: Faculty MentorStudent: Destin Black Period of Grant: 1996
12. Agency: American Cancer Society Amount: $10,000Fellowship AwardRole: Fellow Effort: 100%Period of Grant: 7/94-6/95
12
EDITORIAL DUTIES:
Guest Reviewer
Annals of Surgical Oncology
Cancer
Gastrointestinal Endoscopy
Human Pathology
Journal of Leukocyte Biology
Microcirculation
Social Science & Medicine
Editorial Board
Journal of Clinical Oncology
STUDY SECTIONS:
1997 - 2000 Stiles Grants, Louisiana State University Medical School
2000 - 2001 The Joel J. Roslyn Faculty Award,Association for Academic Surgeons Research Career Development Award
2003 - LSU Research CouncilBridging Grants
13
TEACHING EXPERIENCE:
1994 -1995 Lecturer, Roswell Park Cancer Institute Fellow’s Lecture Series1 lecture per year
1996 - present Clinical Preceptor, Lecturer and Chief Attending Surgeon, Surgical Oncology Service, LSU Health Sciences Center, Shreveport, LA
1996 - present Coordinator, Multidisciplinary Tumor Board,LSU Health Sciences Center Weekly meeting
1996 - present Coordinator, Surgical Oncology Journal Club, LSU Health Sciences CenterWeekly meeting
1996 - present Surgical Oncology Laboratory Meeting, LSU Health Sciences CenterWeekly meeting
1996 - present Faculty, Surgery Grand Rounds,
LSU Health Sciences Center2 lectures per year
1996 - 2000 Faculty, Clinical Medicine 222, LSU Medical School – Shreveport1 lecture per year
1996 - 2000 Faculty, Surgery Resident Basic Science Lectures,
LSU Health Sciences Center1 lecture per year
1996 Lecturer, Willis-Knighton Health System Oncology Series,Shreveport, LA
1996 Invited speaker, Surgery Graduation Day Program, LSU Health Sciences Center
1997 Faculty, 2nd Annual Breast Intervention and Imaging Conference, Shreveport, LA
1997 Instructor, Claiborne Parish Medical Society, Homer, LA
14
1997 Lecturer, Shreveport LPN Society Meeting,Shreveport, LA
1998 Faculty, 9th Annual Northeast LA OB/GYN Society, Monroe, LA
1998 Invited Speaker, YWCA Breast Cancer Forum, Shreveport, LA
1999 Lecturer, Surgical Oncology Centennial Symposium, Roswell Park Cancer Institute, Buffalo, NY
1999 Faculty, 6th Annual Medical – Surgical Conference, Bossier City, LA.
2000 Faculty, Breast Cancer Imaging Seminar,LSU Healthy Sciences Center - Shreveport
2000 Faculty, 7th Annual Regional Medical-Surgical Conference,Shreveport, LA
2000 Invited speaker, Surgery Graduation Day ProgramLSU Health Sciences Center
2000 Lecturer, Feist-Weiller Cancer Center,Shreveport, LA
2000 - present Faculty, 3rd year Surgical Clerkship 8 lectures per year
2001 Faculty speaker, 1st Annual Clinical Symposium, Shreveport, LA
2001 Faculty speaker, Association for Academic Surgery: Fundamentals of Surgical Research Course, Milwaukee, WI
2002-present Coordinator and Lecturer, Fundamentals in Research CourseDept. of Surgery, LSU Health Sciences Center
2002-present Coordinator, Senior Resident Teaching ConferenceDept. of Surgery, LSU Health Sciences Center
2002-present Coordinator, Surgery Research ConferenceDept. of Surgery, LSU Health Sciences Center
15
2002 Freshman Anatomy Course – Clinical Application of Pelvic AnatomyDept. of Anatomy, LSU Medical School
2003 Surgery Grand RoundsSarcoma
2003 Surgery Grand RoundsBreast Cancer
2003 OBGYN Grand RoundsBreast Diseases
2003 Faculty speaker, 5th Annual Red River Gastrointestinal ConferenceShreveport, LA
2003 Faculty, Mock Trial Integrative Processes – Module II2nd medical school curriculum
2003 Surgery Grand RoundsRectal Cancer and Pelvic Recurrence
2004 Surgery Grand RoundsMelanoma
2004 Surgery Grand RoundsEsophageal Cancer
2004 Surgery Grand RoundsSurgical Oncology Research Program
16
MODERATOR/PROGRAM CHAIR OF SCIENTIFIC SESSIONS/EDUCATION PROGRAMS:
1996 Moderator, Scientific SessionJoint Annual Meeting of the Louisiana Chapter, American College of Surgeons and the Surgical Association of LouisianaNew Orleans, LA
2000 Program ChairmanJoint Annual Meeting of the Louisiana Chapter, American College ofSurgeons and the Surgical Association of LouisianaNew Orleans, LA
2001 Moderator,Grantsmanship, Fundamentals in Surgical ResearchAssociation for Academic SurgeryMilwaukee, WI
2002 Oncology Poster Discussion SessionAssociation for Academic SurgeryBoston, MA
2003 Moderator and Chair,Cancer Liaison Physician State MeetingJoint Annual Meeting of the Louisiana Chapter, American College ofSurgeons and the Surgical Association of LouisianaNew Orleans, LA
2003 Moderator, Focused Luncheon Discussion Group on Angiogenesis,Society of University SurgeonsHouston, TX
2003 Panel Discussion on Hormone Replacement Therapy and Cancer-What’s the Evidence?12th Annual Carroll W. Feist SymposiumShreveport, LA
17
2003 Co-Chair, Executive Committee Meeting Development of a Statewide Cancer Plan for LouisianaLouisiana Cancer Control PartnershipBaton Rouge, LA
2004 Co-Chair, Executive Committee Meeting Review of Statewide Cancer Plan for LouisianaLouisiana Cancer Control PartnershipNew Orleans, LA
2004 Moderator and Chair,State of Louisiana Cancer Liaison Physician Annual MeetingNew Orleans, LA
18
LABORATORY/RESEARCH MENTORSHIPS:
Years in Lab Present PositionUndergraduates/High School:
Mathew Dawson 1996 – 1997 Clinical pharmacist, Univ. of Texas Health Sciences Ctr., Tyler, TX
Lauren Griffen 1997 Graduate student, Cornell University, Ithaca, NY
David Googe, M.D. 1997 – 1998 Orthopedics ResidentUniversity of OklahomaOklahoma City, OK
Melissa Macynski 2003 Louisiana CollegePineville, LA
Joshua Lee Jordan 2003 C. E. Byrd High School
Shreveport, LA
Medical/Graduate Students:
Robert DeFatta, M.D., Ph.D. 1996 Otolaryngology Resident,U.T. Southwestern Medical School, Dallas, Tx
Destin Black, M.D. 1996-1997 OB-GYN Resident, LSU Health Sciences Center, Shreveport, LA
Donald Beam, M.D. 1997 Medicine/Pediatrics Resident,LSU Health Sciences Center, Shreveport, LA
Rachel Huot, M.D. 1998 Medicine Resident,
19
Medical College of Virginia,Richmond, VA.
Kerry Byrne 2002 LSU Medical SchoolShreveport, LA
Postgraduate Fellows:
Donald L. Sorrells, M.D. 1996 – 1997 Captain, U. S. Air ForceStaff Surgeon, Wolford Hall, Clinical Assist. Professor of SurgeryUniv. of Texas, San Antonio, TX.
M. Scott Haydon, M.D. 1997 – 1998 Plastics Surgeon,Austin, TX.
William Brown, M.D. 1998 –1999 Colorectal Surgeon,Albuquerque, NM
Paul Perkowski, M.D. 1999 – 2000 Vascular Fellow,Univ. of Arizona,Phoenix, AZ
Jeffrey Gruner, M.D. 2000 –2003 Chief Resident in General Surgery,LSU Health Sciences Center,Shreveport, LA
Stephen White, M.D. 2001 - present General Surgery Resident,LSU Health Sciences CenterShreveport, LA
Kathryn Norton, M.D. 2001 - present General Surgery Resident,LSU Health Sciences CenterShreveport, LA
Derek McClusky, M.D. 2002 - present General Surgery Resident,LSU Health Sciences CenterShreveport, LA
Kerry Byrne, M.D. 2003 General Surgery ResidentLSU Health Sciences CenterShreveport, LA
20
Mohamed Alassas 2003 General Surgery ResidentLSU Health Sciences CenterShreveport, LA
Jay Christopher 2003 General Surgery ResidentLSU Health Sciences CenterShreveport, LA
AWARDS AND HONORS WON BY RESIDENTS/STUDENTS:
Robert DeFatta, M.D., Ph.D. Summer Research Fellowship AwardAmerican Cancer Society
Destin Black, M.D. Summer Research Fellowship AwardAmerican Cancer Society
Student Research AwardSociety of Surgical Oncology
Donald Beam, M.D. Summer Research Fellowship AwardAmerican Cancer Society
Donald L. Sorrells, M.D. Research PrizeSociety of Air Force Clinical Surgeons
Cancer Paper Competition Award LA Chapter, American College of Surgeons
Jeffrey Gruner, M.D. State Cancer Paper Competition WinnerAmerican College of Surgeons, LA-Chapter
Cardelli Research Prize Barlow Cancer SymposiumFeist-Weiller Cancer Center
Derek McClusky, M.D. State Cancer Paper Competition WinnerAmerican College of Surgeons, LA-Chapter
21
REFEREED PUBLICATIONS (Articles, Abstracts, and Proceedings):
1. Li, B.D.L. and Adams, B.G. Identification of a Novel UDPgalactose Pyrophosphorylase Activity in Saccharomyces cerevisiae. Proceedings West Coast Bacterial Physiology, 1980.
2. Adams, B.G. and Li, B.D.L. Detection and Partial Characterization of a Novel UDPgalactose Pyrophosphorylase Activity in Saccharomyces cerevisiae. Proceedings of the Cold Spring Harbor Yeast Conference, 1981.
3. Li, B.D.L., Duda, R.B., and Bauer, K.D. Multiparametric Flow Cytometry for Analysis of c-erbB-2 Oncogene Expression in Breast Cancer. Proceedings of the American Association for Cancer Research 32:204, 1991.
4. Li, B.D.L., Duda, R.B., and Bauer, K.D. Detection of c-erbB-2 Oncoprotein Expression in Breast Tissue by Multiparameter Flow Cytometry. Proceedings of the Assoc. Academic Surgery 25:127, 1991.
5. Li, B.D.L., Byskosh, A., Molteni, A., and Duda, R.B. Estrogen and Progesterone Receptor Status in Recurrent and Metachronous Breast Cancer. Breast Cancer Res. And Treat. 23(1&2):152, 1992.
6. Li, B.D.L., Harlow, S.P., Budnick, R.M., Sheedy, D.L., and Stewart, C.C. Using Competitive PCR to Quantify c-erbB-2 Amplification in Flow Cytometry Sorted Breast Ductal Cells. Breast Cancer Res. Treat. 27(1&2):144, 1993.
7. Casscells, C.D., Lindsey, R.W., Ebersole, J., Li, B.D.L. Ulnar Neuropathy After Median Sternotomy. Clin-Orthop. 291:259-65, 1993.
8. Li, B.D.L., Bauer, K.D., Carney, W.P., and Duda, R.B. Detection of c-erbB-2 Oncoprotein Expression in Breast Tissue by Multiparameter Flow Cytometry. J. Surg. Res. 54: 170-188, 1993.
9. Stewart, C.C., Timm, Jr., E.A., Li, B.D.L., Reidy, M.C., and Harlow, S.P. Molecular Applications of Flow Cytometry. Clinical Immunology Newsletter 13(11): 145-150, 1993.
10. Li, B.D.L., Budnick, R.M., and Stewart, C.C. Using Competitive RT-PCR to Quantify c-myc Expression in Anti-c-myc Oligonucleotide Treated Cells. Proceedings of the American Association for Cancer Research 35:530, 1994.
11. Li, B.D.L., Budnick, R.M., Russo, C.A., Anderson, G.R., and Stewart, C.C. Quantitative Analysis of c-myc Oncogene Expression in Colon Leukemic Cell Lines Treated with c-myc Antisense Phosphorothioate Oligodeoxy-nucleotides. Proceedings of the Assoc. Academic Surgery 28:119, 1994.
12. Li, B.D.L., Harlow, S.P., Budnick, R.M., Sheedy, D.L., and Stewart, C.C. Detection of HER-2/neu Oncogene Amplification in Flow Cytometry Sorted Breast Ductal Cells by Competitive PCR. Cancer 73(11): 2771-2779, 1994.
13. Li, B.D.L., Byskosh, A., Molteni, A., and Duda, R.B. Estrogen and Progesterone Receptors in Primary and Recurrent Breast Cancer. J. Surg. Oncol. 57(2): 71-77, 1994.
14. Li, B.D.L., Budnick, R.M., Sheedy, D.L., and Stewart, C.C. Quantification of HER-2/neu Amplification and Expression in Flow Cytometry Sorted Breast Cancer Cells Using Competitive PCR and RT-PCR. Proceedings of the Soc. Surgical Oncology, 1995.
15. Li, B.D.L., Budnick, R.M., Russo, C.A., Anderson, G.R., and Stewart, C.C. Quantifying c-myc Expression in c-myc Antisense Phosphorothioate Oligonucleotides Treated Leukemic and
22
Colon Cancer Cell Lines. J. Surg. Res. 59: 485-492, 1995.16. McClellan, R., Li, B.D.L., Abreo, F., and De Benedetti, A. Translation Factor eIF-4E
Overexpression as an Adjunct in the Diagnosis of Breast Cancer. Breast Cancer Res. Treat. 41(3):230, 1996.
17. Liu, L., Li, B.D.L., Abreo, F., Kevil, C.G., Alexander, J.S., and De Benedetti, A. The Role of eIF-4E in Vascularization and Progression of Breast Cancer. Translational Control, Cold Spring Harbor Press, pp. 181, 1996.
18. Li, B.D.L., Kerekatte, V., Liu, L., Gelder, F., Abreo, F., and De Benedetti, A. The Detection of Translation Factor eIF-4E Overexpression in Breast Cancer. Proceedings of the Assoc. Academic Surgery 30:122, 1996.
19. Sorrells, D., Black, D.R., Meschonat, C., Rhoads, R.E., De Benedetti, A., Gao, M., Li, B.D.L. Competitve PCR to Detect eIF4E Gene amplification in Breast Cancer. Cancer Symposium 50:43, 1997.
20. Sorrells, D., Meschonat, C., Li, L., De Benedetti, A., Li, B.D.L. Association of the eIF4E Gene Amplification with Malignant Transformation of the Breast. Surgical Forum 68:819-822, 1997.
21. Li, B.D.L., Dawson, M., De Benedetti, A. Clinical Outcome in Breast Cancer with eIF4E Overexpression. Cancer Symposium 50:13, 1997.
22. Li, B.D.L. and Douglass, H.O. Management of the Incidentally Discovered Adrenal Mass or Incidentaloma. J. LA. State Med. Soc. 149:291-299, 1997.
23. Nathan, C.O., Carter, P., Li, L., Li, B.D.L., Abreo, F., Tudor, A., Zimmer, S.G., and De Benedetti, A. Elevated Expression of eIF4E and FGF-2 Isoforms During Vascularization of Breast Carcinomas. Oncogene 15(9): 1087-1095, 1997.
24. Li, B.D.L, Liu, L., Dawson, M., De Benedetti, A. Overexpression of Eukaryotic Initiation Factor 4E in Breast Cancer. Cancer 79(12):2385-2390, 1997.
25. Nathan, C.O., Liu, L., Li, B.D.L., Abreo, F., Nandy, I., De Benedetti, A. Detection of the eIF-4E Oncoprotein at the Surgical Margins of Squamous Cell Cancers of Head and Neck. Oncogene 15(5):579-584, 1997.
26. Sorrells, D., Ghali, G.E., Nathan, C.O., De Benedetti, A., Meschonat, C., DeFatta, R.J., Li, B.D.L. Detection of eIF4E Gene Amplification in Head and Neck Neoplasms. Proceedings of the Society of Head and Neck Surgeons 43:117-118, 1997.
27. Sorrells, D., Meschonat, C., De Benedetti, A., Li, B.D.L. Association of eIF4E Overexpression With Gene Amplification in Breast Cancer. Proceedings of the Society of Air Force Clinical Surgeons 44:104, 1997.
28. Sorrells, D., Meschonat, C., De Benedetti, A., Nathan, C.O., Ghali, G.E, Li, B.D.L. Gene Amplification and Protein Elevantion of eIF4E in Head and Neck Squamous Cell Carcinoma. J. Oral Maxillofacial Surg 55(8) Supp.3:65-66, 1997.
29. McDonald, J.C., De Benedetti, A., Li, B.D.L. Stage I-III Breast Cancer and eIF4E Overexpression. Proceedings of the Southern Surgical Association 109:29-30, 1997.
30. Sorrells, D., De Benedetti, A., Nathan, C.A., Ghali, G.E., Li, B.D.L. eIF4E and Malignant Transformation. Proceedings of the Assoc. Academic Surg. 31:173, 1997.
31. De Benedetti, A., De Fatta, R.J., Li, B.D.L., Abreo, F., Williams, B.J. The Role of eIF4E in Vascularization and Progression of Breast Cancer. Angiogenesis and Cancer, 1998.
32. Brown, W.A., Minnard, E.A., Ampil, F. Burton, G. Li, B.D.L. Breast Conservation Therapy: A Difficult Management Decision. Breast Cancer Res. Treat. 50(3):246, 1998.
33. Hedden, W.J., Perry, L.S., Minnard, E.A., Morris, D.M., Schwalke, M.A., White, R.K., Spires,
23
W.V., Li, B.D.Li. Scalpel Versus Electrocautery in Modified Radical Mastectomy Revisited: A Randomized Prospective Study. Breast Cancer Res. Treat. 50(3):268, 1998.
34. Li, B.D.L., Liu, L., Abreo, F., Sorrells, D., De Benedetti, A. Expression of eIF4E in Ductal Carcinoma In Situ (DCIS). Cancer Symposium 51:22, 1998.
35. Haydon, M.S., Googe, J.D., Meschonat, C., Sorrels, D., Ghali, G., Minnard, E., Li, B.D.L. EIF4E Gene Amplification and Malignant Progression in Head and Neck Cancers. J. Oral Maxillofacial Surg. 56(8) Supp. 4:51, 1998.
36. Li, B.D.L., Minnard, E., and Nava, H. Cystic Tumors of the Pancreas - A Review. J. LA. State Med. Soc. 150(1):16-24,1998.
37. Li, B.D.L., McDonald, J.C., Nassar, R., and De Benedetti, A. Clinical Outcome in Stage I to III Breast Cancer and eIF4E Overexpression. Ann. Surg. 227(5):756-763, 1998.
38. Sorrells, D., Black, D.R., Meschonat, C., Rhoads, R.E., De Benedetti, A., Gao, M., Li, B.D.L. Detection of eIF4E Gene amplification in Breast Cancer by Competitive PCR. Ann. Surg. Oncol. 5(3):232-237, 1998.
39. Ghali, G.E., Li, B.D.L., Minnard, E.A. Management of the Neck Relative to Oral Malignancy. Selected Readings in Oral and Maxillofacial Surgery 6(2): 1-36, 1998.
40. Haydon, M.S., Googe, J.D., Meschonat, C., Gautreaux, M., Williams, J., De Benedetti, A., Eggerstedt, J., Nathan, C.A., Li, B.D.L. The Detection of Eukaryotic Initiation Factor 4E (eIF4E) in Solid Tumors. Proc. Assoc. Acad. Surgery, 32:167, 1998.
41. Ampil, F., Burton, G., Li, B.D.L., Minnard, E.A., Person, K., Etheridge, L., Abreo, F., Mills, G., Chin, H. Is The Timing Of Radiotherapy After Breast Conservation Surgery For Early Stage Cancer Important? Eur. J. Cancer 34(5):S61, 1998.
42. Brown, W.A., Minnard, E.A., Ampil, F. Burton, G., Li, B.D.L. Breast Conservation Therapy in an Indigent Population: A Difficult Management Decision. Proceedings Southeastern Surg 67:19, 1999.
43. Huot, R.I., Brown, W.A., Googe, J.D., Minnard, E.A., Ghali, G.E., Li, B.D.L. Differential Effects of Nicotine on Cell Proliferation and Eukaryotic Initiation Factor 4E (eIF4E) Expression in Normal and Malignant Cell Lines. Proceedings American Assoc. for Cancer Research, 40:491, 1999.
44. Haydon, M.S., Googe, J.D., Ghali, G.E., Minnard, E.A., Li, B.D.L. Progressive eIF4E Gene Amplification Associated with Malignant Transformation of Head and Neck Tumors. Proceedings Soc. Surg. Oncol. 52:18, 1999.
45. Ghanta, M.K. Minnard, E.A., Fontenot, A. M., Li, B.D.L. Initiation of a Sentinel Node Biopsy Program at a University Program. American Surgeon 65(12):1202, 1999.
46. Brown, W., Lowery, M. Yu, H., Li, B.D.L. EIF4E Overexpression as a Predictor of Breast Carcinoma Outcome Relative to other Standard Prognostic Markers. American Surgeon 65(12):1203, 1999.
47. Li, B.D.L., Brown, W.A., Burton, G.V., Yu, H., Ampil, F., McDonald, J.C. Patient Compliance is Critical For Equivalent Clinical Outcomes For Breast Cancer Treated By Breast Conservation Therapy. Proceedings of the Southern Surgical Association 111:56-57, 1999.
48. Ampil, F.L, Burton, G.V., Li, B.D.L., Mills, G.M., Patil, R. The Omission of Postoperative Regional Lymphatic Irradiation in Early Breast Cancer: Harmful or Not? Proceedings Int’l. Gyn. Cancer Society 7:59-63, 1999.
49. Ampil, F.L., Burton, G.V., Li, B.D.L., Minnard, E., Mills, G.M. Radiotherapy With and Without Chemotherapy After Breast Conservation Surgery for Early Stage Cancer: A Review of Timing. Eur. J. Gynaec. Oncol. 20(4):254-257, 1999.
24
50. Burke, J.B., Cunningham, M., Li, B.D.L. Squamous Cell Carcinoma Arising from a Chronic Ulcer Secondary to Spina Bifida. Surgical Rounds 22(7):368-374, 1999.
51. Sorrels, D., Meschonat, C., Black, D., Li, B.D.L. Pattern of eIF4E Gene Amplification and Overexpression in Solid Tumor. J. Surg. Res. 85:37-42, 1999.
52. Sorrells, D.L., Ghali, G.E., De Benedetti, A., Nathan, C.A., Li, B.D.L. Progressive Amplification and Overexpression of the eIF4E Gene in the Different Zones of Head and Neck Cancers. J. Oral Maxillofac Surgery 57(3):294-299, 1999.
53. De Fatta, R.J., Turbat-Herrera, E., Li, B.D.L., Anderson, W., De Benedetti, A. Elevated Expression of eIF4E in Confined Early Breast Cancer Lesions: Possible Role of Hypoxia. International J. Cancer 80:516-522, 1999.
54. Johnson, L.W., Sehon, J., Li, B.D.L. Potential Utility of Sentinel Node Biopsy in the Original Assessment of Hurthle Cell Tumors of the Thyroid: 23-Year Institutional Review of Hurthle Cell Neoplasms. J. Surgical Oncology 70:100-102, 1999.
55. Sorrells, D., Ghali, G.E., Meschonat, C., DeFatta, R.J., Black, D., Liu, L.,De Benedetti, A., Nathan, C.O.,and Li, B.D.L. Competitive PCR to Detect eIF4E Gene Amplification in Head and Neck Cancer. Head & Neck 21:60-65, 1999.
56. Mills, G.M., Ratts, V., Yu, H., Ampil, F., Burton, G.V., Li, B.D.L. Combined Modality Therapy of Esophageal Cancer. Anticancer Treatment, 2000.
57. Li, B.D.L., Brown, W.A., Burton, G.V., Yu, H., Ampil, F., McDonald, J.C. Patient Compliance is Critical For Equivalent Clinical Outcomes For Breast Cancer Treated By Breast Conservation Therapy. Ann Surg 231(6): 883-889, 2000
58. Ghali, G.E. and Li, B.D.L. Management of Cancer of the Lip. Selected Readings in Oral and Maxillofacial Surgery 8(4):1-23, 2000.
59. Haydon, M.S., Googe, B.S., Sorrells, D.L., Ghali, G.E., Li, B.D.L. Progression of eIF4E Gene Amplification and Overexpression in Benign and Malignant Head and Neck Tumors. Cancer 88(12):2803-2810, 2000.
60. Carrico, J., Person, K., Shi, R., Burton, E., Richard, M., Li, B.D.L., Ampil, F., Patil, R., Burton, G. Lymphedema in Breast Cancer Patients. Proceedings of the International Symposium on Supportive Care in Cancer 8:248, 2000.
61. Yu H., Shu X.O., Li B.D.L., Dia Q., Berkel H., Ji F., Zheng W. High Insulin-like Growth Factors (IGFs) And IGF Binding Protein-3 (IGFBP-3) are Associated With Breast Cancer Risk In Chinese Women. Proceedings of the American Assoc. for Cancer Research 41:128, 2000.
62. Li, B. D. L., Khosravi, M. J., Berkel, H. J., Diamandis, A., Dayton, M. A., Smith, M., Yu, H. Free Insulin-like Growth Factor-I (IGF-I) And Breast Cancer Risk. Proceedings of the American Assoc. for Cancer Research. 41:222, 2000.
63. White, S.C. Haydon, M.S., Li, B.D.L. Complete Axillary Node Dissection is Associated With a Low Incidence of Lymphedema and Axillary Recurrence. American Surgeon 66(12): 1188, 2000.
64. Norton, K.S., Alley, J.A., Li, B.D.L. Locally Advanced Breast Cancer – Do African Americans Have a Worse Prognosis? American Surgeon 66(12): 1186, 2000.
65. Perkowski, P.E., Burton, G., Ampil, F., Li, B.D.L. Multimodal Therapy for Esophageal Carcinoma. Proceedings of the Southeastern Surgical Congress 68:95, 2000.
66. Brown, W., Lowery, M. Yu, H., Li, B.D.L. eIF4E, TNM, ER Status, and HER-2/neu Overpexression as Predictors of Breast Cancer Outcome SSO. Cancer Symposium 20:36, 2000.
67. Gruner, J.S., Perkowski, P.E., Yu, H., Abreo, F., Li, B.D.L. High eIF4E Overexpression Predicts a Worse Outcome in Stage I to III Breast Cancer. Proceedings of the Soc. Of Univ.
25
Surgeons 62:25, 2001.68. Li, B. D. L., Khosravi, M. J., Berkel, H. J., Diamandis, A., Dayton, M. A., Smith, M., Yu, H.
Free Insulin-like Growth Factor-I (IGF-I) And Breast Cancer Risk. International J. Cancer 91:736-739, 2001.
69. McClusky, D., Gauthier, M., Brown, W.A., Etheridge, L., Li, B.D.L. An Active Intervention Protocol to Improve Breast Conservation Therapy Clinical Outcome. Proceedings of the American Soc. Breast Surgeons, 2001.
70. Ampil, F.L., Burton, G.V., Li, B.D.L. “Routine” Weekly Blood Counts During Breast Irradiation for early Stage Cancer – Are They Really Necessary? The Breast Journal 7(6):450-452, 2001.
71. Ampil, F.L., Caldito, G., Li, B.D.L., Pelser, R. Computed Tomographic Staging of Esophageal Cancer and Prognosis. Radiation Medicine 19(3): 127-129, 2001.
72. Perkowski, P.E., Abreo, F., Meschonat, C., Li, B.D.L. Eukaryotic Initiation Factor 4E Overexpression is Associated with VEGF Elevation in Breast Carcinoma. Cancer Symposium 54: 40, 2001.
73. Dayton, M.A., Li, B.D.L., Smith, M., Berkel, H., Yu, H. Plasma Levels of IGF-I are Correlated with IGF-I Expression in Breast Cancer Patients, But not in the Control Women. Proceedings of the American Assoc. for Cancer Research 42:153, 2001.
74. Yu, H., Li, B.D.L., Smith, M., Glass, J. Plasma Levels of IGFs and HER/neu in Breast Cancer. Proceedings of the American Assoc. for Cancer Research 42:153-154, 2001.
75. Yu, H., Singal, R., Smith, M., Glass, J., Li, B.D.L. Methylation of p16 in Peripheral Blood Cells and Breast Cancer. Proceedings of the American Assoc. for Cancer Research 42:151, 2001.
76. Yu, H., Li, B.D.L., Smith, M., Shi, R., Berkel, H., Kato, I. Polymorphic length of CA Repeats in the IGF-I Gene and Breast Cancer Risk. Amer. Soc. Prev. Oncol. 25:43, 2001.
77. White, S.C., Haydon, M.S., Li, B.D.L. Risk for Recurrence and Lymphedema is Low After a Complete Axillary Node Dissection. Proceedings of the American Assoc. for Cancer Research 42:858, 2001.
78. Lehrich, D.A., Yu, H., Li, B.D. L., Mansour, R. Breast Cancer and Circulating Levels of Insulin Growth Factors (IGFs) and IGF Binding Protein (IGFBP-3: A Study of Clinical and Pathologic Correlation. Proceedings of the American Soc. Clinical Oncology 20:324b, 2001.
79. Kunjumoideen, K.K., Burton, B.V., Ampil, F.L., Li, B.D.L., Mills, G.M., Shi, R. Breast Size and the Risk of Local and Distant Recurrence in Breast Conserved and Irradiated Patients with Early Breast Cancer: A Retrospective Review of 78 Cases. Proceedings of the American Soc. Clinical Oncologist 20:36b, 2001.
80. Norton, K., Alley, J., Burton, G., Ampil, F., Li, B.D.L. Compliance and Outcomes: Do African Americans with Advanced Breast Cancer Fare Worse? Proceedings of the American Assoc. Cancer Research 42:890, 2001.
81. Li, A., Dionyssios, K., Abreo, F., Fracchioli, S., Turbat-Herrera, E.A., Singal, R.M., Li B.D.L., Yu, H. Expression of p16 Tumor Supressor Gene in Epithelial Ovarian Cancer. Proceedings of the U.S. and Canadian Academy of Pathology, 2001.
82. Li, B.D.L., Gruner, J.S., Yu, H., Abreo, F.W., Johnson, L.W., Nawas, S., DeBenedetti, A., McDonald, J.C. A Prospective Study on the Risk for Breast Cancer Recurrence in Patients with eIF4E Protein Elevation. Proceedings of the Southern Surgical Assoc. 113: 62-63, 2001.
83. Yu, H., Li, B.D.L., Smith, M., Shi, R., Kato, K. Polymorphic CA Repeats in the IGF-I and Breast Cancer, Breast Cancer Research and Treatment 70:117-122, 2001.
26
84. Li, B.D.L., Gruner, J.S., Abreo, F.W., Meschonat, C.J., Gauthier, M., Yu, H. eIF4E Overexpression is Associated with VEGF and Microvessel Density Elevation, and a Worse Breast Cancer Outcome. Proceedings of the Soc. of University Surgeons 63:65, 2002.
85. Ampil, F.L., Burton, G.V., Li, B.D.L., Mills, G.M. Breast Size, Local Relapse, and Prognosis After Breast Preserving Therapy for Early Breast Cancer. Proceedings of the 3rd European Breast Cancer Conference, 2002.
86. Norton, K., Li, B.D.L., Johnson, L.W. Sestamibi Scan As A Preoperative Screening Tool, Proceedings of the Southeastern Surgical Congress 70:21, 2002.
87. Norton, K.S., White, S.C., Abreo, F.W., Yu, H., Meschonat, C., Li, B.D.L. Correlating eIF4E Overexpression With Serum and Specimen IGF-1 And IGFBP3 Level in Breast Cancer. Proceedings American Association for Cancer Research 43: 917, 2002.
88. Yu, H., Shu, X.O., Li, B.D.L., Dia, Q., Shi, R., Gao, Y.T., Jin, F., Zheng, W. Joint Effect Of IGF And Sex Steroid Hormones On Breast Cancer Risk. Proceedings of the American Assoc. for Cancer Research 43:236, 2002.
89. Gruner, J.S., Perkowski, P., Meschonat, C.J., Abreo, F.W., Johnson, L.W., Alley, J-A., Nawas, S., Yu, H., Li, B.D.L. High eIF4E Overexpression Predicts a Worse Outcome in Stage I to III Breast Cancer. The American Surgeon 68(1):107-8, 2002.
90. Norton, K.S., DeBenedetti, A., Meschonat, C., Gauthier, M., Yu, H., and Li, B.D.L. Induction of a Novel Kinase by eIF4E in Breast Carcinoma, J. Surgical Research 107:329-330, 2002.
91. Norton, K.S., De Benedetti, A., Yu, H., Meschonat, C., Gauthier, M., and Li, B.D.L. eIF4E Level in Node Negative Breast Cancer – An Interim Analysis. Proceedings of the Dept. of Defense Breast Cancer Research Program, Vol. 1:P8-16, 2002.
92. Ampil, F., Caldito, G., Taneja, C., Burton, G.V., Li, B.D.L. Supraclavicular Nodal Relapse of Breast Cancer: Prevalence Palliation and Prognosis. Proceedings of the 4th Lynn Sage Breast Cancer Symposium, 2002.
93. Constantinescu, M., Abreo, F., Kunjumoideen, K., Li, B.D., Gruner, J.S., Shi, R., Lowry-Nordberg, M., Lack of Correlation Between Expression of Eukaryotic Initiation 4E and Other Prognostic Markers in Breast Infiltrating Ductal Carcinoma. Am J. Clin. Path. 118:626, 2002.
94. Ampil, F., Burton, G., Mills, G., Li, B.D.L. Incidence and Treatment Outcome of Patients with Cauda Equina Compression By Metastatic Breast Cancer. Proceedings of the 4th Shanghai International Conference on Radiation Oncology, 2002.
95. Li, B.D.L., Gruner, J.S., Abreo, F., Johnson, L.W., Yu, H., Nawas, S., McDonald, J.C., DeBenedetti, A. Prospective Study of eIF4E Protein Elevation and Breast Cancer Outcome.Ann. Surg. 235(5)732-739, 2002.
96. Yu, H., Jin, F., Shu, X-O, Li, B.D.L., Qi, D., Cheng, J-R, Berkel, H.J., Zheng, W. Insulin-like Growth Factors and Breast Cancer Risk in Chinese Women. Cancer Epidemiology, Biomarkers & Prevention 11:705-712, 2002.
97. Norton, K., Johnson, L.W., Griffen, F.D., Burker, J., Kennedy, S., Aultman, D., Li, B.D.L., Zibari, G. Sestamibi Scan As A Preoperative Screening Tool, The American Surgeon 68:812-815, 2002.
98. White, S.C., Gauthier, M., Taneja, C., and Li, B.D.L., A Conservative Approach to Elderly Patients with Breast Cancer Does Not Affect Outcome, Annals of Surg Oncol 10(1): S59, 2003.
99. McClusky, D., Gauthier, M., Meschonat, C., Chu, Q., Li, B.D.L. High eIF4E Predicts Cancer Recurrence in Node-positive Breast Carcinoma. Proceedings of the American Association for Cancer Research, 44:297, 2003.
27
100.McClusky, D., Gauthier, M., Meschonat, C., Chu, Q., Alley, J.A., Sehon, K., Johnson, L.W., Li, B.D.L. High eIF4E Predicts Recurrence in Node-negative Breast Cancer Patients. Proceedings of the American Society for Clinical Oncology, 22:851, 2003.
101.Yu, H., Shu, X-O, Shi, R., Dai, Q., Jin, F., Gao, Y-T., Li, B.D.L., Zheng, W. Plasma Sex Steroid Hormones and Breast Cancer in Chinese Women, International J Cancer 105:92-97, 2003.
102.Ampil, F.L. Caldito, G., Li, B.D.L., Burton, G.V. Supraclavicular Nodal Relapse of Breast Cancer: Prevalence, Palliation and Prognosis. Eur J Gynaec Oncol 24(3-4): 233235, 2003.
103.Kato, I., Eastham, J., Li, B.D.L., Smith, H., Yu, H. Genotype-phenotype Analysis for the Pleomorphic CA Repeat in the Insulin-Like Growth Factor-I (IGF-I) Gene. Eur J Epidemiology 18:203-209, 2003.
104.Ethridge, L., Macynski, M., Chu, Q., McClusky, Turnage, R., Li, B.D.L. Referral to American Cancer Society May Not Improve the Quality of Life for Patients with Breast Cancers. Proceedings of the Lynn Sage Breast Cancer Symposium 5:B7, 2003.
105.Chu, Q.D., Turnage, R.H., Burton, G., Ampil, F., McDonlad, J.C., Li, B.D.L. Neoadjuvant Chemotherapy Attenuates the Overexpression of eIF4E in Patients with Breast Carcinomas. Proceedings of the 2nd Annual AACR Frontiers in Cancer Prevention Research 2:86-87, 2003.
106.Yu, H., Shu, X-O, Li, B.D.L., Dai, Q., Gao, Y-T., Jin, F., Zheng, W. Joint Effect of Insulin-like Growth Factors and Sex Steroids on Breast Cancer Risk. Cancer Epid., Biomarkers & Prevention 12:1067-1073, 2003.
107.Chu, Q.D., D. McClusky, Turnage, R.H., Johnson, L.W., McDonald, J.C., Li, B.D.L. Impact Of eIF4E Overexpression On Survival In Advanced Breast Cancer. Annals of Surg Oncol 11(2): 42, 2004.
108.Chu, Q.D., Turnage, R., McClusky, D., Meschonat, C., Li, B.D.L. Overexpression of Eukaryotic Initiation Factor 4E (eIF4E) in Soft Tissue Neoplasms. Proceedings of the AACR 45:4285, 2004.
109.Chu, Q., Johnson, L.W., Li, B.D.L. Management of Retroperitoneal Sarcoma. Journal of the LA State Medical Society 156(2):95-98, 2004.
110.Hargon, C.G., Burtion, G.V., Li, B.D.L., Ampil, F., Lillian, D. 6FDG PET Imaging of Suspicious Breast Lesions Developing After Breast Conservation Therapy for Breast Cancer. Proceedings of the ASCO 23:30, 2004.
111.White, S., Ampil F., Burton G., Li B.D.L., Chu Q. Is Breast Conservation an Acceptable Alternative for Breast Cancer Patients with Collagen Vascular Diseases? Annals of Surg Oncol 11(2): 43, 2004.
112.Wolfort, R.M., Li, B.D.L., Ramaswamy, M., Turnage, R.T., Ampil, F., Burton, G. Chu, Q.D. The Role of Positron Emission Tomography in the Detection of Metastasis in Symptomatic Patients with Stage II and III Breast Cancer. Proceedings of the ASCO 23:56, 2004.
113.Connor, M.S., Li, B.D.L., Ramaswamy, M., Turnage, R.T., Chu, Q.D. PET-Positive Thyroid Incidentalomas: Characteristics and Risks of Malignancy Obsereved in a Tertiary Referral Center. Proceedings of the ASCO 23:495, 2004.
114.Norton, K.S., McClusky, D., Siddhartha, S., Yu, H., Meschonat, C., DeBenedetti, A., Li, B. D.L. TLK1B Is Elevated With eIF4E Overexpression in Breast Cancer. J Surg Res 116: 98-103, 2004.
28
CHAPTERS, EDITORIALS, AND OTHER NON-REFEREED PUBLICATIONS:
1. Li, B.D.L. A Study of a Novel Galactose Inducible Uridine Diphosphate Galactose Pyrophosphorylase Activity in Saccharomyces cerevisiae. Arch. Univ. Hawaii,1982.
2. Li, B.D.L. Deiodination of Thyroxine by Two NADP-Dependent Rat Liver Microsomal Deiodinase Activities. Arch. Yale Univ. Sch. Med., 1986.
3. Li, B.D.L., Timm, Jr., E.A., Reidy, M.C., Harlow, S.P., and Stewart, C.C. Molecular Phenotyping in Flow Cytometry. In: Z. Darzynkiewicz and H.A. Crissman (Eds.), Methods in Cell Biology Vol.42, pp.95-130, Academic Press: San Diego, 1994.
4. Li, B.D.L. [Book Review] Surgery for Gastrointestinal Cancer - A Multidisciplinary Approach. By Harold J. Wanebo, M.D. Philadelphia: Lippincott-Raven, 1996. Gastrointestinal Endoscopy 46(5):484-485, 1997.
5. Li, B.D.L., Ghali, G.E., Minnard, E.A. Cancer of the Anterior (Oral) Tongue. In: T.J. Saclarides, K.S. Millikan, C.V. Godellas (Eds.), Surgical Oncology – An Algorithmic Approach, pp.24- 32, Springer-Verlag: New York, 2003.
Accepted For Publication:
1. Turnage, R.H., Li, B.D.L., McDonald, J.C. Abdominal Wall, Umbilicus, Peritoneum, Mesenteris, Omentum, and Retroperitoneum. In Sabiston, Textbook of Surgery.
2. Zhang, J., Dai, Q., Shridhar, R., Yin, L., Sloane, B.F., Miller, F., Meschonat, C., Li, B.D.L. Li, Abreo, F., Keppler, D. Cystatin M, A Novel Candidate Tumor Suppressor
Gene for Breast Cancer. Cancer Research
29
Submitted For Publication:
1. Gruner, J., Abreo, F., Yu, H., Perkowski, P.E., Meschonat, C., Gauthier, M., Sehon, J.K., Alley, J.A., Li, B.D.L. Correlation of Tumor eIF4E Overexpression with VEGF Elevation, Microvessel Density and Breast Cancer Outcome.
2. Wood, C., Byrne, K., Lynn, M., Burton, G.V., Ampil, F., Abreo, F., Li, B.D.L. Ectopic Breast Carcinoma in an Immunosuppressed Renal Transplant Recipient: A Case Report and Review of World Literature.
3. Christopher, J.W., Cunningham, M.W., Valiulis, J.P., Li, B.D.L. Marjolin’s Ulcer in a Diabetic Foot.
4. Sikes, J.W., Ghali, G.E., Li, B.D.L. Head and Neck Sarcoma: Five Case Reports and a Review of the Literature.
5. Thomas, J.P., Rath, S., Li, B.D.L., Zibari, G. Leiomyosarcoma of the Inferior Vena Cava: A Case Report.
6. Haydon, M.S., Googe, J.D., Williams, B.J., Eggerstedt, J., Li, B.D.L. Eukaryotic Initiation Factor 4E (eIF4E) in Five Solid Tumors.
7. Perkowski, P.E., Ampil, F.L., Burton, G.V., Li, B.D.L. A Multidisciplinary Approach to Esophageal Cancer is Feasible for a Predominantly Indigent, Minority Population.
8. Steiner, D.C., Li, A., Abreo, F., Li, B.D.L., Burton, G.V. Racial Differences in the Extent of Ductal Carcinoma In-Situ (DCIS) Associated with Invasive Breast Cancer.
9. Tran, N., Bharaj, B.S., Mayne, S., Smith, M., Diamandis, E.P., Li, B.D.L., Yu, H. IGF-I Polymorphism and Breast Cancer risk – Does Laboratory Method Affect Findings?
10. Chu, Q.D., Li, J., Byrne, K., McClusky, D., Okadata, Y., De Benedetti, A., Mathis, J.M., and Li, B.D.L. A Translational Restricted HSV-TK/GCV Gene Increases Disease-Free and Overall Survival in a Minimal Residual Disease Rat Breast Cancer Model.
INVITED LECTURESHIPS AND PRESENTATIONS:
1. "Molecular Techniques in Detecting HER-2 in Breast Cancer" Drapanas Lectureship, State Univ. of New York, Buffalo, NY. May, 1993.
2. "Cystic Tumors of the Pancreas”Roswell Park Cancer Institute. Buffalo, NY. Sept., 1994.
3. “The Incidentally Discovered Adrenal Mass or Incidentaloma" Roswell Park Cancer Institute. Buffalo, NY. Sept., 1995.
4. “Quantifying c-myc Expression in c-myc Antisense Phosphorothioate Oligodeoxynucleotides Treated Leukemic and Colon Cancer Cell Lines”
30
Roswell Park Cancer Institute Scientific Retreat. Amherst, NY. May, 1995.5. “Surgical Approach to Oncology"
LSU Medical School. Shreveport, LA. March, 1996.6. "Breast Cancer"
LSU Medical School. Shreveport, LA. March, 1996.7. "Applications of Quantitative PCR in Oncology"
Graduation Day Lecture, LSUMC Dept. of Surgery. Shreveport, LA. May, 1996.8. “Molecular Biology of Solid Tumors"
Basic Science Lecture, LSUMC Dept. of Surgery. Shreveport, LA. June, 1996.9. “Ductal Carcinoma In Situ - Role of Mastectomy Versus Breast Conservation”
Willis-Knighton Hospitals, Shreveport, LA. Oct., 1996.10. “Management and Treatment of Breast Disease”
Women Forever: Women’s Health Through the Life Span. Shreveport, LA. Dec., 1996.11. “Current Issues in the Management of Ductal Carcinoma In Situ (DCIS)”
2nd Annual Breast Intervention and Imaging Conference. Shreveport, LA. April, 1997.12. “Tumor Biology: Oncogenes and Malignant Transformation”
LSUMC Dept. of Surgery. Shreveport, LA. April, 1997.13. “Breast Cancer Screening”
Shreveport LPN Society Meeting. Shreveport, LA. May, 1997.14. “Management of Recurrent Colorectal Cancer”
Claiborne Parish Medical Society. Homer, LA. July, 1997.15. “Surgical Oncology – Basic Science Review I”
Basic Science Lecture Series, LSUMC Dept. of Surgery. Shreveport, LA. Dec., 1997.16. “Surgical Oncology – Basic Science Review II”
Basic Science Lecture Series, LSUMC Dept. of Surgery. Shreveport, LA. Nov., 1997.17. Invited Panelists on Breast Cancer Forum
YWCA. Shreveport, LA, 1998.18. “Issues and Controversies in Breast Cancer Care”
9th Annual Northeast LA OB/GYN Society. Monroe, LA, 1998.19. “Updates on Breast Cancer Detection and the Management of in situ carcinomas”
9th Annual Northeast LA OB/GYN Society. Monroe, LA, 1998.20. “Breast Cancer Therapy at the End of the 20th Century”
The Hadassah Meeting. Shreveport, LA, 1999. 21. “Update on Current Surgical Oncology Protocols”
Grand Rounds for Family Practice, LSUHSC, Shreveport, LA, 1999.22. “Breast Conservation Therapy and Sentinel Node Biopsy”
Breast Cancer Imaging Seminar. Shreveport, LA, 1999.23. “Advances in Breast Conservation Therapy”
6th Annual Medical – Surgical Conference. Bossier City, LA, 1999.24. “Eukaryotic Initiation Factor 4E (eIF4E) and its Implications in Solid Tumors”
Surgical Oncology Centennial Symposium - Roswell Park Cancer Institute. Buffalo, NY, 1999.25. “The Role of Eukaryotic Initiation Factor 4E (eIF4E) in Malignant Transformation”
Graduation Day Lecture, LSUHSC, Shreveport, LA, 2000.26. “New Frontiers in Surgical Oncology”
7th Annual Regional Medical-Surgical Conference. Shreveport, 2000.27. “Malignant Transformation in Solid Tumors – The Possible Role of eIF4E”
31
2 Feist-Weiller Cancer Center, Shreveport, LA, 2000.28.2
“Update on Sarcoma Therapy” Willis Knighton Cancer Center Meeting, Shreveport, LA, 2001.
29.3
“Advances in Surgical Oncology” 1st Annual Clinical Symposium, Shreveport, LA, 2001.
30.3
“Research Grantsmanship” 12th Annual AAS Fundamentals in Surgical Research, Milwaukee, WI, 2001.
31. “Advances in Breast Cancer”Cancer Survivor Meeting, Shreveport, LA, 2002.
32. “Highlights of the Changes in the AJCC Staging of Cancers” Christus-Schumpert Medical System, Shreveport, LA, 2002.
33. “Breast – What a Mass It Could Be”LSUHSC Department of Surgery Grand Rounds, Shreveport, LA, 2003.
34. “Rectal Cancer and Pelvic Recurrence”LSUHSC Department of Surgery Grand Rounds, Shreveport, LA 2003.
35. “Management of Sarcoma”LSUHSC Department of Surgery Grand Rounds, Shreveport, LA, 2003.
36. “The Management of Pelvic Recurrence Following Operation for Rectal Cancer”5th Annual Red River Gastrointestinal Conference, Shreveport, LA, 2003.
37. “Surgical Management of Breast Diseases”LSUHSC Department of OB-GYN Grand Rounds, Shreveport, LA, 2003.
38. “Surgical Approach to Breast Cancer”Multi-disciplinary Breast Cancer Imaging Update Symposium, Shreveport, LA, 2003.
39. “Breast Cancer Screening and Treatment”Feist-Weiller Cancer Center Luncheon Symposium, Shreveport, LA, October, 2003.
40. “Pelvic Anatomy – Clinical Correlation”Anatomy Course for 1st year medical students, LSUHSC – Shreveport, LA, 2003
41. “Melanoma – Biology and Practice Principles”LSUHSC Department of Surgery Grand Rounds, Shreveport, LA, 2004.
42. “Esophageal Cancer Treatment Guidelines: Rationale And/Or Rationalization”LSUHSC Dept. of Surgery Grand Rounds, Shreveport, LA, 2004.
PRESENTATIONS AT PROFESSIONAL MEETINGS:
19801. Identification of a Novel UDPgalactose Pyrophosphorylase Activity in Saccharomyces
cerevisiaWest Coast Bacterial Physiology Conference, Asilomar, CA
32
19812. Detection and Partial Characterization of a Novel UDPgalactose Pyrophosphorylase Activity in
Saccharomyces cerevisiae. Cold Spring Harbor Yeast Conference, Cold Spring Harbor, NY
19913. Multiparametric Flow Cytometry for Analysis of c-erbB-2 Oncogene Expression in Breast
Cancer.American Association for Cancer Research, Houston, TX
4. Detection of c-erbB-2 Oncoprotein Expression in Breast Tissue by Multiparameter Flow Cytometry. Association for Academic Surgery, Colorado Springs, CO
19925. Estrogen and Progesterone Receptor Status in Recurrent and Metachronous Breast Cancer.
Breast Cancer Symposium, San Antonio, TX
19936. Using Competitive PCR to Quantify c-erbB-2 Amplification in Flow Cytometry Sorted Breast
Ductal Cells. Breast Cancer Symposium, San Antonio, TX
19947. Using Competitive RT-PCR to Quantify c-myc Expression in Anti-c-myc Oligonucleotide
Treated Cells. American Association for Cancer Research, San Francisco, CA
8. Quantitative Analysis of c-myc Oncogene Expression in Colon Leukemic Cell Lines Treated with c-myc Antisense Phosphorothioate Oligodeoxy-nucleotides. Association for Academic Surgery, Albuquerque, NM
19959. Quantification of HER-2/neu Amplification and Expression in Flow Cytometry Sorted Breast
Cancer Cells Using Competitive PCR and RT-PCR. Society of Surgical Oncology, Boston, MA
199610. The Detection of Translation Factor eIF-4E Overexpression in Breast Cancer.
Assoc. Academic Surgery, Chicago, IL11. Translation Factor eIF-4E Overexpression as an Adjunct in the Diagnosis of Breast Cancer.
Breast Cancer Symposium, San Antonio, TX 12. The Role of eIF-4E in Vascularization and Progression of Breast Cancer.
Translational Control, Cold Spring Harbor, NY
1997
33
13. eIF4E and Malignant Transformation.Association for Academic Surgery, Dallas, TX
14. Clinical Outcome in Breast Cancer with eIF4E Overexpression.Society of Surgical Oncology, Chicago, IL
15. Gene Amplification and Protein Elevation of eIF4E in Head and Neck Squamous Cell Carcinoma.American Oral Maxillofacial Surgery, Seattle, WA
16. Stage I-III Breast Cancer and eIF4E Overexpression.Southern Surgical Association, Hot Spring, VA
17. Detection of eIF4E Gene Amplification in Head and Neck Neoplasms.Society of Head and Neck Surgeons, Cancun, Mexico
18. Detection of eIF4E Gene Amplification in Breast Cancer by Competitive PCR. Louisiana Chapter, American College Surgeons, New Orleans, LA
19. Competitive PCR to Detect eIF4E Gene amplification in Breast Cancer.Society of Surgical Oncology, Chicago, IL
20. Association of the eIF4E Gene Amplification with Malignant Transformation of the Breast. American College of Surgeons, Chicago, IL
21. Association of eIF4E Overexpression With Gene Amplification in Breast Cancer.Society of Air Force Clinical Surgeons, Sacramento, CA
199822. The Detection of Eukaryotic Initiation Factor 4E (eIF4E) in Solid Tumors.
Association for Academic Surgery, Seattle, WA23. EIF4E Gene Amplification and Malignant Progression in Head and Neck Cancers.
American Oral Maxillofacial Surgery, New Orleans, LA24. Expression of eIF4E in Ductal Carcinoma In Situ (DCIS).
Society of Surgical Oncology, San Diego, CA25. Scalpel Versus Electrocautery in Modified Radical Mastectomy Revisited: A Randomized
Prospective Study.Breast Cancer Symposium, San Antonio, TX
26. Breast Conservation Therapy: A Difficult Management Decision.Breast Cancer Symposium, San Antonio, TX
27. Multimodality Therapy for Esophageal Carcinoma.LA Chapter, American College of Surgeons, New Orleans, LA
28. Breast Conservation Therapy: A Difficult Management Decision. LA Chapter, American College of Surgeons, New Orleans, LA
29. Eukaryotic Initiation Factor 4E (eIF4E) and Malignant Transformation in Head and Neck Squamous Cell Carcinoma. LA Chapter, American College of Surgeons, New Orleans, LA
30. The Role of eIF4E in Vascularization and Progression of Breast Cancer.Angiogenesis and Cancer, Cold Spring Harbor, NY
199931. Progressive eIF4E Gene Amplification Associated with Malignant Transformation of Head and
Neck Tumors.Society of Surgical Oncology, Orlando, FL
34
32. Differential Effects of Nicotine on Cell Proliferation and Eukaryotic Initiation Factor 4E (eIF4E) Expression in Normal and Malignant Cell Lines.American Association for Cancer Research, Philadelphia, PA
33. Breast Conservation Therapy in an Indigent Population: A Difficult Management Decision.Southeastern Surgical Congress, Tampa, FL
34. Eukaryotic Initiation Factor 4E (eIF4E) and its Implications in Solid Tumors.Surgical Oncology Centennial Symposium - Roswell Park Cancer Institute. Buffalo, NY
35. Neoadjuvant Chemoradiation Therapy for Extremity Sarcoma.LA Chapter, American College of Surgeons, New Orleans, LA
36. Patient Compliance is Critical For Equivalent Clinical Outcomes For Breast Cancer Treated By Breast Conservation Therapy.Southern Surgical Association, Hot Spring, VA
200037. Initiation of a Sentinel Node Biopsy Program at a University Program.
LA Chapter, American College of Surgeons, New Orleans, LA38. eIF4E Overexpression as a Predictor of Breast Carcinoma Outcome Relative to other Standard
Prognostic Markers.LA Chapter, American College of Surgeons, New Orleans, LA
39. Lymphedema in Breast Cancer Patients. 11th International Symposium, Supportive Care in Cancer, Denver, CO
40. High Insulin-like Growth Factors (IGFs) And IGF Binding Protein-3 (IGFBP-3) are Associated With Breast Cancer Risk In Chinese Women.American Association for Cancer Research, San Francisco, CA
41. Free Insulin-like Growth Factor-I (IGF-I) And Breast Cancer Risk.American Association for Cancer Research, San Francisco, CA
42. eIF4E, TNM, ER Status, and HER-2/neu Overpexression as Predictors of Breast Cancer Outcome. Society of Surgical Oncology, New Orleans, LA
43. Multimodal Therapy for Esophageal Carcinoma. Southeastern Surgical Congress, Orlando, FL
2001 44. High eIF4E Overexpression Predicts a Worse Outcome in Stage I to III Breast Cancer.
Society of University Surgeons, Chicago, IL45. Eukaryotic Initiation Factor 4E Overexpression is Associated with VEGF Elevation in Breast
Carcinoma.Society of Surgical Oncology, Washington D.C.
46. Compliance and Outcomes: Do African Americans with Advanced Breast Cancer Fare Worse? American Assoc. for Cancer Research, New Orleans, LA
47. Plasma Levels of IGF-I are Correlated with IGF-I Expression in Breast Cancer Patients, But not in the Control Women.American Assoc. for Cancer Research, New Orleans, LA
48. Plasma Levels of IGFs and HER/neu in Breast Cancer.American Assoc. for Cancer Research, New Orleans, LA
35
49. Methylation of p16 in Peripheral Blood Cells and Breast Cancer.American Assoc. for Cancer Research, New Orleans, LA
50. Expression of p16 Tumor Supressor Gene in Epithelial Ovarian Cancer. U.S. and Canadian Academy of Pathology, Montreal, Canada
51. Polymorphic Length of CA Repeats in the IGF-I Gene and Breast Cancer Risk. American Society of Preventive Oncology, Toronto, Canada
52. Risk for Recurrence and Lymphedema is Low After a Complete Axillary Node Dissection.American Assoc. for Cancer Research, New Orleans, LA
53. Breast Cancer and Circulating Levels of Insulin Growth Factors (IGFs) and IGF Binding Protein (IGFBP-3): A Study of Clinical and Pathologic Correlation.American Society of Clinical Oncologist, San Francisco, CA
54. Breast Size and the Risk of Local and Distant Recurrence in Breast Conserved and Irradiated Patients with Early Breast Cancer: A Retrospective Review of 78 Cases. American Society of Clinical Oncologist, San Francisco, CA
55. Research Grantsmanship. Association for Academic Surgery - Fundamentals in Surgical Research, Milwaukee, WI
56. Locally Advanced Breast Cancer – Do African Americans Have a Worse Prognosis? LA Chapter, American College of Surgeons, New Orleans, LA
57. Complete Axillary Node Dissection is Associated With a Low Incidence of Lymphedema and Axillary Recurrence.LA Chapter, American College of Surgeons, New Orleans, LA
58. An Active Intervention Protocol to Improve Breast Conservation Therapy Clinical Outcome. American Society of Breast Surgeons, Boston, MA
59. A Prospective Study on the Relative Risk for Breast Cancer Recurrence in Patients with eIF4E Protein Elevation. Southern Surgical Association, Hot Springs, VA
200260. eIF4E Overexpression is Associated with VEGF and Microvessel Density Elevation, and a
Worse Breast Cancer Outcome.Society of University Surgeons, Honolulu, HI
61. Sestamibi Scan As A Preoperative Screening Tool.Southeastern Surgical Congress, Nashville, TN
62. Correlating eIF4E Overexpression With Serum and Specimen IGF-1 And IGFBP3 Level in Breast Cancer.American Assoc. for Cancer Research, San Francisco, CA
63. Joint Effect of IGF And Sex Steroid Hormones On Breast Cancer Risk.American Assoc. for Cancer Research, San Francisco, CA
64. High eIF4E Overexpression Predicts a Worse Outcome in Stage I to III Breast Cancer. LA Chapter, American College of Surgeons, New Orleans, LA
65. eIF4E Level in Node Negative Breast Cancer – An Interim Analysis. Dept. of Defense – Breast Cancer Research Program, Era of Hope, Orlando, FL
66. Induction of a Novel Kinase by eIF4E in Breast Carcinoma.Association for Academic Surgery, Boston, MA
36
67. Breast Size, Local Relapse, and Prognosis After Breast Preserving Therapy for Early Breast Cancer.3rd European Breast Cancer Conference, Barcelona, Spain
68. Supraclavicular Nodal Relapse of Breast Cancer: Prevalence palliation and Prognosis. 4th Lynn Sage Breast Cancer Symposium, Chicago, IL
69. Incidence and Treatment Outcome of Patients with Cauda Equina Compression By Metastatic Breast Cancer. 4th Shanghai International Conference on Radiation Oncology, Shanghai, China
70. Lack of Correlation Between Expression of Eukaryotic Initiation 4E and Other Prognostic Markers in Breast Infiltrating Ductal Carcinoma. Society of Clinical Pathologist
200371. High eIF4E is Associated with TLK1B Elevation and Breast Cancer Recurrence.
Society of Univ. Surgeons, Houston, TX72. High eIF4E Predicts Cancer Recurrence in Node-positive Breast Carcinoma.
American Association for Cancer Research, Washington D.C.73. A Conservative Approach to Elderly Patients with Breast Cancer Does Not Affect Outcome.
Society of Surgical Oncology, Los Angeles, CA74. High eIF4E Overexpression is Associated with TLK1B Elevation and Breast Cancer
Recurrence.Joint Annual Meeting of the LA-Chapter, American College of Surgeons & Surgical Association of Louisiana, New Orleans, LA
75. High eIF4E Predicts Recurrence in Node-Negative Breast Cancer Patients. American Society for Clinical Oncology, Chicago, IL
76. High eIF4E Predicts Cancer Recurrence in Node-positive Breast Carcinoma. American Association for Cancer Research, Washington D.C.
77. Referral to American Cancer Society May Not Improve the Quality of Life for Patients with Breast Cancers. Lynn Sage Cancer Symposium, Chicago, IL
78. Neoadjuvant Chemotherapy Attenuates the Overexpression of eIF4E in Patients with Breast Carcinomas. Frontiers in Cancer Prevention Research, AACR, Phoenix, AZ
200479. Thoracic Metastases From Breast Cancer: A 23 Year Review of Patients.
Barlow Symposium, Shreveport LA 80. Impact of eIF4E Overexpression On Survival In Advanced Breast Cancer.
Joint Annual Meeting of the LA-Chapter, American College of Surgeons & Surgical Association of Louisiana, New Orleans, LA
81. Eukaryotic Initiation Factor 4E (eIF4E) is Overexpressed in Patients with Soft Tissue Neoplasms.American Association for Cancer Research, Orlando, FL
82. Overexpression of eIF4E is Attentuated Following Neoadjuvant Chemotherapy for Patients with Breast Carcinomas.Barlow Symposium, Shreveport, LA
37
83. eIF4E Overexpression Portend a Poorer Survival for Patients with Advanced Breast Cancer.Barlow Symposium, Shreveport, LA
84. The Risk for malignancy in PET-Positive Thyroid Incidentalomas.American Society of Clinical Oncology, New Orleans, LA
85. Cystatin M: A Novel Candidate Tumor Suppressor of Breast Cancer.Barlow Symposium, Shreveport, LA
86. 6FDG PET Imaging of Suspicious Breast Lesions Developing After Breast Conservation Therapy for Breast Cancer.American Society of Clinical Oncology, New Orleans, LA
87. Therapeutic Efficacy of Translational Restricted Modified HSK-TK/GCV Gene Therapy Following Tumor Cytoreduction in a Syngeneic Rat Model for Breast Cancer.Barlow Symposium, Shreveport, LA
88. Breast Conservation Therapy Can Be An Acceptable Alternative For Breast Cancer Patients With Collagen Vascular Disease.Society of Surgical Oncology, NYC, NY
89. Positron Emission Tomography is a Useful Modality for the Detection of Metastasis in Symptomatic Patients with Stage II and III Breast Cancer.American Society of Clinical Oncology, New Orleans, LA
90. Impact Of eIF4E Overexpression On Survival In Advanced Breast Cancer. Society of Surgical Oncology, NYC, NY
38
MEDIA PRESENTATIONS:
1. “Breast Cancer Screening”. Shreveport Cable Vision, Shreveport, LA, Nov., 1996.
2. “Breast Cancer Treatment”. Shreveport Cable Vision, Shreveport, LA, Dec., 1996.
3. “Surgical Aspects of Oncology”. Shreveport Cable Vision, Shreveport, LA, Sept., 1997.
4. “Partners in Wellness: Cancer Screening”. Shreveport Cable Vision, Shreveport, LA, February, 2001.
5. “Update on G.I Malignancies”. KTBS (ABC Affiliate), Shreveport, LA, May 2001.
6. “Sentinel Node Biopsy in Breast cancer”. KTBS (ABC Affiliate), Shreveport, LA, May 2001.
7. “Breast Cancer Screening”. KTAL (NBC Affiliate), Shreveport, LA, October, 2001.
8. “Breast Cancer Awareness”. KEEL (Clear Channel Affiliate), Shreveport, October, 2003.
9. “Gene Therapy and Cancer”. KSLA (CBS Affiliate), Shreveport, LA, January, 2004.
39